✨ Your Portfolio is fetched and updated from zerodha.
Large CDMO

Divi's Laboratories Ltd.

DIVISLAB

Market Cap
₹1,76,087 Cr.
P/E
67.54

Divi's Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1.76 L Cr
PE
PE
67.54
Prom Holding
Prom Holding
51.88 %
ROE (%)
ROE (%)
14.64
ROCE (%)
ROCE (%)
18.87
Div Yield (%)
Div Yield (%)
0.45
Sales
Sales
10,560 Cr
OPM (%)
OPM (%)
32.59 %
Debt to Equity
Debt to Equity
0.00
Institutions
Institutions
39.51 %
Individual < 2 lac
Individual < 2 lac
5.99 %
No. of Shareholders
No. of Shareholders
2.28 L
View more
Edit Ratio's

About

Divi's Laboratories is a pharmaceutical company specializing in the manufacture of Active Phar… Read more
Low
5637
52W Range
High
7072
  • Divi's Lab
  • Laurus Labs
  • Acutaas Chemicals
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Brand Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Neogen Chemicals Ltd.
    • Tatva Chintan Pharma Chem Ltd.
    • HLE Glascoat Ltd.

    FAQs on Divi's Laboratories Ltd. Business

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Divi's Laboratories Ltd.
    None
    Divi's In A Nutshell - Harsh Doshi
    Detailed analysis on Divi’s Laboratories - A Mega Cap Compounding Machine - Value Educator
    Detailed Analysis Of Divi's Labs & Business Model - Value Educator
    Nutraceuticals- Industry Overview - Value Educator
    Divis: A Megacap Multibagger - SOIC
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material